Drugs online research references









  • mRNA and protein expression of dog liver cytochromes P450 in relation to the metabolism of human CYP2C substrates.
  • Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
  • The state of immune system and effects of current therapy and immunomodulators
  • Therapeutic tactics for treating patient with duodenal ulcer complicated my hemorrhage
  • The effect of commonly used drugs on angiogenesis.
  • Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori.
  • Structural and functional characterization of gastric mucosa and central nervous system in histamine H2 receptor-null mice.
  • Lansoprazole overutilization: methods for step-down therapy.
  • Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
  • Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era.
  • Impact of cotherapy with some proton pump inhibitors on medical claims among HMO patients already using other common drugs also cleared by cytochrome P450.
  • Antralization at the edge of proximal gastric ulcers: does Helicobacter pylori infection play a role?
  • The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
  • Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance.
  • Relaxant effect of omeprazole and lansoprazole in guinea pig gallbladder muscle strips in vitro.
  • Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy.
  • Sildenafil, a phosphodiesterase-5 inhibitor, delays gastric emptying and gastrointestinal transit of liquid in awake rats.
  • Divalent cations regulate acidity within the lumen and tubulovesicle compartment of gastric parietal cells.
  • Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.
  • CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability.
  • Impact of a formulary change in proton pump inhibitors on health care costs and patients' symptoms.
  • Probing CYP2C19 and CYP3A4 activities in Chinese liver microsomes by quantification of 5-hydroxyomeprazole and omeprazole sulphone.
  • Peptic ulcer occurrence in follow-up of chronic gastritis in patients with treated and not eradicated CagA-positive Helicobacter pylori infection.
  • Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment
  • Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog.
  • The effectiveness of 7-day combined Helicobacter eradication therapy in patients with peptic ulcer and chronic gastritis
  • Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora.
  • Relations of acid-base balance and gastric secretion of hydrogen carbonate ions in patients with peptic ulcer
  • Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.
  • Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.
  • Are children with cystic fibrosis who are treated with a proton-pump inhibitor at risk for vitamin B(12) deficiency?
  • Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats.
  • Duodenal fat intensifies the perception of heartburn.
  • Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model.
  • Endogenous gastrin stimulates regeneration of remnant pancreas after partial pancreatectomy.
  • Rx drugs
  • Rx drugs
  • Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
  • Diagnostic methods for detecting forms and strains of Helicobacter pylori and evaluation of its eradication.
  • Effect of long-term omeprazole treatment on antral G and D cells in children.
  • Antiulcerogenic effect of Hippophae rhamnoides L.
  • Hypergastrinemia in response to gastric inflammation suppresses somatostatin.
  • Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
  • Clinical efficacy of proton pump inhibitor therapy in neurologically impaired children with gastroesophageal reflux: prospective study.
  • A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.
  • Proton pump inhibitors: a study of GPs' prescribing.
  • Interaction of sleep disturbances and gastroesophageal reflux in chronic laryngitis.
  • Rx drugs
  • Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.
  • Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine.
  • Omeprozole therapy in pediatric patients after liver and intestinal transplantation.
  • Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.
  • Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus.
  • The incidence of non ulcer dyspepsia and its response to treatment.
  • Protease-activated receptor-2 (PAR-2) in the rat gastric mucosa: immunolocalization and facilitation of pepsin/pepsinogen secretion.
  • In-vitro activity of rabeprazole, lansoprazole, and esomeprazole against Helicobacter pylori
  • Circadian monitoring of intragastric pH in evaluation of efficiency of antisecretory therapy of duodenal ulcer
  • Gastroprotective activity of solidagenone on experimentally-induced gastric lesions in rats.
  • Effect of omeprazole-induced achlorhydria on trefoil peptide expression in the rat stomach.
  • Conformational analysis: a new approach by means of chemometrics.
  • Regression of duodenal gastric metaplasia in Helicobacter pylori positive patients with duodenal ulcer disease.
  • The effects of rabeprazole on parietal cells and enterochromaffin-like cells in rats: a comparison with omeprazole.
  • Nizatidine and omeprazole enhance the effect of metronidazole on Helicobacter pylori in vitro.
  • Prolonged use of proton pump inhibitors, CagA status, and the outcome of Helicobacter pylori gastritis.
  • Effect of omeprazole on regional and temporal variations in intragastric acidity.
  • Wine stimulates gastric acid secretion in isolated rabbit gastric glands via two different pathways.
  • Determination of omeprazole in bulk and injectable preparations by liquid chromatography.
  • Failure of Helicobacter pylori eradication: is poor compliance the main cause?
  • Influence of Helicobacter pylori infection on healing and relapse of acetic acid ulcers in Mongolian gerbils.
  • Anti-ulcerogenic and analgesic activities of the leaves of Wilbrandia ebracteata in mice.
  • Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity.
  • Chronic gastric ulcer healing in rats subjected to selective and non-selective cyclooxygenase-2 inhibitors.
  • The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations
  • Prevalence of H. pylori-infection in family members of H. pylori positive and its influence on the reinfection rate after successful eradication therapy: a two-year follow-up.
  • Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.
  • Effect of omeprazole on oral and intravenous RS-methadone pharmacokinetics and pharmacodynamics in the rat.
  • Antileishmanial activity of the antiulcer agent omeprazole.
  • Efficacy of a paste formulation of omeprazole for the treatment of naturally occurring gastric ulcers in training standardbred racehorses in Canada.
  • Effect of various antisecretory drugs on morphological changes in rat gastric mucosa in experimental stomach ulcers
  • Rx drugs
  • Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences
  • Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori.
  • Assessment of the afferent vagal nerve in patients with gastroesophageal reflux.
  • Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
  • Laryngopharyngeal reflux symptoms improve before changes in physical findings.
  • Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
  • A cell-based reporter gene assay for determining induction of CYP3A4 in a high-volume system.
  • Submicroscopic aspects of the mechanism of inhibitors of H+/K+-ATPase in gastric parietal cells
  • Odds of moderate or severe gastric ulceration in racehorses receiving antiulcer medications.
  • Asymmetries in H+/K+-ATPase and cell membrane potentials comprise a very early step in left-right patterning.
  • Rx drugs
  • Prospective study on the incidence of chronic ear complaints related to gastroesophageal reflux and on the outcome of antireflux therapy.
  • Rx drugs
  • Long-term curative effects of suture plus proximal gastric vagotomy or triad-therapy for duodenal ulcer with acute perforation
  • Long-term effects of Helicobacter pylori eradication in Mongolian gerbils.
  • Effect of long-term, continuous versus alternate-day omeprazole therapy on serum gastrin in patients treated for reflux esophagitis.
  • Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.
  • High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes.
  • Gastric polyps and nodules in children receiving long-term omeprazole therapy.
  • Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism.
  • Lansoprazole quantification in human plasma by liquid chromatography-electrospray tandem mass spectrometry.
  • Modulation of the phototoxic effect of hypericin in human leukemia CEM cell line by N-ethylmaleimide, amiloride and omeprazole.
  • Effect of proton pump inhibitors on the continuous real time (13)C-urea breath test.
  • Interaction between various resistance modifiers and apoptosis inducer 12H-benzoalphaphenothiazine.
  • Hydrogen-potassium ATPase inhibitors induce relaxation on rabbit prostatic strips in vitro.
  • Anti-Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene.
  • Antimicrobial activity of esomeprazole versus omeprazole against Helicobacter pylori.
  • Adsorptive voltammetric behavior of omeprazole and its application
  • Adenocarcinoma of the rat esophagus in the presence of a proton pump inhibitor: a pilot study.
  • Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
  • Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage.







    DreamPharm: Herbal and Nutritional supplements online || Hair Million herbal formula for hair loss and hair growth || Antibiotics and prescription medications online literature ||